Key developments in pharmaceutical manufacturing – September 2023
European Pharmaceutical Review
OCTOBER 12, 2023
With the goal of supplying cell therapies, vaccines and other essential medicines such as antibody drugs to patients, the facilities aim to address major supply challenges and navigate the intricacies of producing fragile biological products. Subject to planning permission, the site is expected to be opened by 2028. The new £26.4
86 
Let's personalize your content